Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
4.85%
Price
08:00
€294.70
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 4.85%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.871% | -4.871% |
| iShares Core DAX® | 1.352% | 0.930% |
| iShares Nasdaq 100 | 3.277% | 4.990% |
| iShares Nikkei 225® | 7.434% | 16.599% |
| iShares S&P 500 | 1.702% | 2.244% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat